Nuvelution Pharma, Inc.

(No Reviews)
601 Gateway Blvd #1270, South San Francisco, CA 94080, USA

Nuvelution Pharma, Inc. is located in San Mateo County of California state. On the street of Gateway Boulevard and street number is 601. To communicate or ask something with the place, the Phone number is (650) 866-8065. You can get more information from their website.
The coordinates that you can use in navigation applications to get to find Nuvelution Pharma, Inc. quickly are 37.6582393 ,-122.3993946

Contact and Address

State: California
Address: 601 Gateway Blvd #1270, South San Francisco, CA 94080, USA
Postal code: 94080
Phone: (650) 866-8065
Website: http://nvtpharma.com/

Location & routing

Get Directions

Reviews

There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Nuvelution Pharma, Inc., use the form below and your opinion, advice or comment will appear in this space.

Write a Review


Nuvelution Pharma, Inc. On the Web

Contact - Nuvelution Pharmaceuticals

Nuvelution Pharma, Inc. 101 Main Street, Suite 1210 Cambridge, MA 02142   Phone  :   (650) 866


September 19, 2017 - Nuvelution Pharmaceuticals

Jerusalem and San Francisco, CA, September 19, 2017 - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome (TS) in pediatric patients in the United States.


Joseph Poirier | Nuvelution Pharma Inc | ZoomInfo.com

View Joseph Poirier's business profile and see work history, affiliations and more.


Betsy Garofalo | Nuvelution Pharma Inc | ZoomInfo.com

Wrong Betsy Garofalo? Update Profile. Betsy Garofalo Expert CNS Consultant at Nuvelution Pharma Inc. Wrong Betsy Garofalo? Update Profile. ... (650) 866-8065. Email:


Teva and Nuvelution Pharma Partner to ... - Pharmaceutical-tech

Teva Pharmaceutical Industries Ltd. and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome (TS) in pediatric patients in the United States.


Nuvelution Pharma Appoints Kirk Ways, M.D., Ph.D., as Chief ...

Nuvelution Pharma, Inc., today announced that Kirk Ways M.D., Ph.D., has been named Chief Medical Officer effective immediately. Dr. Ways is a seasone


Nuvelution Pharma Announces Commencement of Patient ...

SAN FRANCISCO--(BUSINESS WIRE)-- Nuvelution Pharma, Inc. today announced the initiation of patient enrollment in the Phase II/III ... (650) 866-8065 United States


Scrip

Nuvelution Pharma Inc. Phone: (650) 866-8065 601 Gateway Boulevard Suite 1270 South San Francisco, CA 94080 USA Advertisement You must sign in to use this functionality


Teva and Nuvelution Pharma Partner to Accelerate Development ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Nuvelution Pharma, Inc. today announced their partnership to develop AUSTEDO® (deutetrabe ... Sandy Zweifach, 650-866-8065 ...